<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04895800</url>
  </required_header>
  <id_info>
    <org_study_id>2019-563</org_study_id>
    <nct_id>NCT04895800</nct_id>
  </id_info>
  <brief_title>An Evaluation of the Effects of a Non-Caffeinated Energy Dietary Supplement</brief_title>
  <official_title>An Evaluation of the Effects of a Non-Caffeinated Energy Die-tary Supplement on Cognitive and Physical Performance: A Randomized Double-Blind Placebo-Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Southeastern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Southeastern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study tested the effects of a botanical blend to a caffeine and a placebo condition on&#xD;
      1) self-reported alertness, anxiety, and headaches 2) multiple measures of attention 3)&#xD;
      physical performance and 4) stress biomarkers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aimed to build on this work by investigating the possibility that a specific&#xD;
      botanical blend (Phytovive™); comprised of Bacopa monnieri bacosides, Kaempferia parviflora&#xD;
      methoxy flavones, pomegranate peel polyphenols, and Moringa oleifera leaf saponins) could&#xD;
      improve cognitive and physical performance. To this end, this study was a randomized,&#xD;
      double-blind, placebo-controlled 21-day parallel study on 36 healthy adults. The study&#xD;
      compared the effects of the botanical blend at baseline to a caffeine and a placebo condition&#xD;
      on 1) self-reported alertness, anxiety, and headaches 2) multiple measures of attention 3)&#xD;
      physical performance and 4) stress biomarkers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 3, 2020</start_date>
  <completion_date type="Actual">March 15, 2021</completion_date>
  <primary_completion_date type="Actual">January 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A Randomized Double-Blind Placebo-Controlled Study</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cognition</measure>
    <time_frame>21 days</time_frame>
    <description>Cognitive performance on the NIH Toolbox Cognition Battery and Joggle Psychomotor Vigilance Task. T scores (higher is better) will be reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mood</measure>
    <time_frame>21 Days</time_frame>
    <description>Self-reported Mood using the Mood and Physical Sensation Scale (higher scores reflect better mood)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical Performance</measure>
    <time_frame>21 Days</time_frame>
    <description>Time to Exhaustion (TTE) Test - running on a treadmill with an increased incline every minute until perceived exhaustion is reached</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Health Behavior</condition>
  <arm_group>
    <arm_group_label>Herbal Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(Phytovive™); comprised of Bacopa monnieri bacosides, Kaempferia parviflora methoxy flavones, pomegranate peel polyphenols, and Moringa oleifera leaf saponins)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Green tea caffeine extract (170 mg; to deliver 34 mg caffeine [20% natural caffeine]),</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Flavored placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Phytovive</intervention_name>
    <description>Bacopa monnieri bacosides, Kaempferia parviflora methoxy flavones, pomegranate peel polyphenols, and Moringa oleifera leaf saponins)</description>
    <arm_group_label>Herbal Supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Natural Flavors [Chocolate, Caramel, Vanilla Cream], Silica, Inulin, Sucralose)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>Caffeine (Green tea caffeine extract (170 mg; to deliver 34 mg caffeine [20% natural caf-feine])</description>
    <arm_group_label>Caffeine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult males and females from 18 to 50 years (inclusive) of age who are physically&#xD;
             active and have been engaging in athletic and sporting endeavors consistently over a&#xD;
             period of 6 months at minimum&#xD;
&#xD;
          -  BMI 18.0 (normal) to 34.9 (obese, class I) kg/ m2 inclusive&#xD;
&#xD;
          -  Agrees to maintain a stable lifestyle with no change in exercise or diet for the&#xD;
             duration of the study&#xD;
&#xD;
          -  Current consumer of caffeine either through caffeinated beverages or foods&#xD;
&#xD;
          -  Non-smoker&#xD;
&#xD;
          -  Able to physically exercise, to run on a treadmill at moderate to high intensity for a&#xD;
             brief time (typically less than 20 min)&#xD;
&#xD;
          -  Participants with normal blood pressure or participants with hypertension that is&#xD;
             controlled (BP &lt; 160/90 and who are on medication at a stable dose (same dose for ≥90&#xD;
             days)&#xD;
&#xD;
          -  Willing and able to agree to the requirements and restrictions of this study, be&#xD;
             willing to give voluntary consent, be able to understand and read the questionnaires,&#xD;
             carry out all study-related procedures, communicate effectively with the study staff.&#xD;
&#xD;
          -  Females must be using an acceptable method of contraception such as: abstinence,&#xD;
             double barrier (condom, diaphragm, or cervical cap with spermicidal foam, gel, or&#xD;
             cream), intrauterine device or hormonal contraception (oral, injectable, implantable,&#xD;
             transdermal, or vaginal) used consecutively for at least 3 months prior to screening&#xD;
             visit, vasectomized partner or use of implants for at least 6 months prior to&#xD;
             screening visit; bilateral tubal ligation, hysterectomy, bilateral oophorectomy, or be&#xD;
             postmenopausal status with amenorrhea (no menses) for at least 1 year prior to the&#xD;
             screening visit.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have a known sensitivity or allergy to any of the study products or their ingredients&#xD;
&#xD;
          -  Have any medical condition or disease based on the professional judgement and&#xD;
             experience of the principal investigator (PI) plus research industry standards that&#xD;
             might affect or impact the administration of study products&#xD;
&#xD;
          -  Lactating, pregnant or planning to become pregnant during the study&#xD;
&#xD;
          -  History of drug or alcohol abuse in the 12 months prior to screening&#xD;
&#xD;
          -  History of psychiatric illness requiring hospitalization in the 6 months prior to&#xD;
             screening&#xD;
&#xD;
          -  History of diabetes (Type I or II) or uncontrolled hypertension (either systolic BP&#xD;
             &gt;160 or diastolic BP &gt;90)&#xD;
&#xD;
          -  Participation in or use of a research IP within 30 days prior to screening (cannot&#xD;
             have been in another study within 30 days of screening)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaime Tartar, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nova Southeastern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nova Southeastern University</name>
      <address>
        <city>Davie</city>
        <state>Florida</state>
        <zip>33314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Norman Scholfield C. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528-35. doi: 10.1016/j.jep.2013.11.008. Epub 2013 Nov 16. Review.</citation>
    <PMID>24252493</PMID>
  </reference>
  <reference>
    <citation>Heaton RK, Akshoomoff N, Tulsky D, Mungas D, Weintraub S, Dikmen S, Beaumont J, Casaletto KB, Conway K, Slotkin J, Gershon R. Reliability and validity of composite scores from the NIH Toolbox Cognition Battery in adults. J Int Neuropsychol Soc. 2014 Jul;20(6):588-98. doi: 10.1017/S1355617714000241. Epub 2014 Jun 24.</citation>
    <PMID>24960398</PMID>
  </reference>
  <reference>
    <citation>Pickering C, Kiely J. What Should We Do About Habitual Caffeine Use in Athletes? Sports Med. 2019 Jun;49(6):833-842. doi: 10.1007/s40279-018-0980-7. Review.</citation>
    <PMID>30173351</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 17, 2021</study_first_submitted>
  <study_first_submitted_qc>May 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nova Southeastern University</investigator_affiliation>
    <investigator_full_name>Jaime Tartar</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

